Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice

Ankit Jain*, Shivakumar Chitturi, Geoffrey Peters, Desmond Yip

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    11 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice'. Together they form a unique fingerprint.

    Medicine and Dentistry